Blockade of the dorsal hippocampal dopamine D1 receptors inhibits the scopolamine-induced state-dependent learning in rats

Neuroscience

Volumn 252, Issue , 2013, Pages 460-467

  Piri, M ^a   Rostampour, M ^b   Nasehi, M ^c   Zarrindast, M R ^d,e,f,g  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f INSTITUTE FOR RESEARCH IN FUNDAMENTAL SCIENCES IPM   (Iran)

^g Institute for Cognitive Science Studies   (Iran)

Author keywords

Dopamine D1 receptors; Dorsal hippocampus; Inhibitory avoidance memory; Rat; Scopolamine; State dependent memory

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ACETYLCHOLINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; SCOPOLAMINE; UNCLASSIFIED DRUG;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINE RECEPTOR BLOCKING; DRUG DOSE COMPARISON; HIPPOCAMPAL CA1 REGION; INTRAHIPPOCAMPAL DRUG ADMINISTRATION; MALE; MEMORY DISORDER; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; STATE DEPENDENT LEARNING;

1-PHENYL-7,8-DIHYDROXY-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE HYDROCHLORIDE; ACETYLCHOLINE; ACH; ANALYSIS OF VARIANCE; ANOVA; CA1; CAMP/PKA; CYCLIC AMP/PROTEIN KINASE A; DA; DOPAMINE; DOPAMINE D1 RECEPTORS; DORSAL HIPPOCAMPAL; DORSAL HIPPOCAMPUS; INHIBITORY AVOIDANCE MEMORY; INTRA-CA1; INTRA-DORSAL HIPPOCAMPAL; R(+)-7-CHLORO-8-HYDROXY-3-METHYL-1-PHENYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE HYDROCHLORIDE; RAT; SCH23390; SCOPOLAMINE; SKF38393; STATE-DEPENDENT MEMORY;

AMNESIA; ANIMALS; CA1 REGION, HIPPOCAMPAL; CHOLINERGIC ANTAGONISTS; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; INJECTIONS, INTRAVENTRICULAR; LEARNING; MALE; MEMORY; MICROINJECTIONS; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; SCOPOLAMINE HYDROBROMIDE;

EID: 84885073193     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2013.08.003     Document Type: Article

References (48)

1. Azami N.S., Piri M., Oryan S., Jahanshahi M., Babapour V., Zarrindast M.R. Involvement of dorsal hippocampal alpha-adrenergic receptors in the effect of scopolamine on memory retrieval in inhibitory avoidance task. Neurobiol Learn Mem 2010, 93:455-462.
2. Azizbeigi R., Ahmadi S., Babapour V., Rezayof A., Zarrindast M.R. Nicotine restores morphine-induced memory deficit through the D1 and D2 dopamine receptor mechanisms in the nucleus accumbens. J Psychopharmacol 2011, 25:1126-1133.
3. Bartus R.T. On neurodegenerative diseases, models, and treatment strategies: lessons learned and lessons forgotten a generation following the cholinergic hypothesis. Exp Neurol 2000, 163:495-529.
4. Berrard S., Varoqui H., Cervini R., Israel M., Mallet J., Diebler M.F. Coregulation of two embedded gene products, choline acetyltransferase and the vesicular acetylcholine transporter. J Neurochem 1995, 65:939-942.
5. Berse B., Blusztajn J.K. Coordinated up-regulation of choline acetyltransferase and vesicular acetylcholine transporter gene expression by the retinoic acid receptor alpha, cAMP, and leukemia inhibitory factor/ciliary neurotrophic factor signaling pathways in a murine septal cell line. J Biol Chem 1995, 270:22101-22104.
6. Blokland A. Acetylcholine: a neurotransmitter for learning and memory?. Brain Res Brain Res Rev 1995, 21:285-300.
7. Collerton D. Cholinergic function and intellectual decline in Alzheimer's disease. Neuroscience 1986, 19:1-28.
8. Drain P., Folkers E., Quinn W.G. CAMP-dependent protein kinase and the disruption of learning in transgenic flies. Neuron 1991, 6:71-82.
9. Fibiger H.C. Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence. Trends Neurosci 1991, 14:220-223.
10. Fibiger H.C., Damsma G., Day J.C. Behavioral pharmacology and biochemistry of central cholinergic neurotransmission. Adv Exp Med Biol 1991, 295:399-414.
11. Fujishiro H., Umegaki H., Suzuki Y., Oohara-Kurotani S., Yamaguchi Y., Iguchi A. Dopamine D2 receptor plays a role in memory function: implications of dopamine-acetylcholine interaction in the ventral hippocampus. Psychopharmacology (Berl) 2005, 182:253-261.
12. Gallagher M., Colombo P.J. Ageing: the cholinergic hypothesis of cognitive decline. Curr Opin Neurobiol 1995, 5:161-168.
13. Gasbarri A., Verney C., Innocenzi R., Campana E., Pacitti C. Mesolimbic dopaminergic neurons innervating the hippocampal formation in the rat: a combined retrograde tracing and immunohistochemical study. Brain Res 1994, 668:71-79.
14. Gasbarri A., Sulli A., Packard M.G. The dopaminergic mesencephalic projections to the hippocampal formation in the rat. Prog Neuropsychopharmacol Biol Psychiatry 1997, 21:1-22.
15. Hartvig P., Nordberg A., Torstenson R., Sjoberg P., Fasth K.J., Langstrom B. Interaction of a muscarinic cholinergic agonist on acetylcholine and dopamine receptors in the monkey brain studied with positron emission tomography. Dement Geriatr Cogn Disord 2002, 13:199-204.
16. Hefco V., Yamada K., Hefco A., Hritcu L., Tiron A., Nabeshima T. Role of the mesotelencephalic dopamine system in learning and memory processes in the rat. Eur J Pharmacol 2003, 475:55-60.
17. Hersi A.I., Richard J.W., Gaudreau P., Quirion R. Local modulation of hippocampal acetylcholine release by dopamine D1 receptors: a combined receptor autoradiography and in vivo dialysis study. J Neurosci 1995, 15:7150-7157.
18. Hersi A.I., Rowe W., Gaudreau P., Quirion R. Dopamine D1 receptor ligands modulate cognitive performance and hippocampal acetylcholine release in memory-impaired aged rats. Neuroscience 1995, 69:1067-1074.
19. Imperato A., Obinu M.C., Gessa G.L. Stimulation of both dopamine D1 and D2 receptors facilitates in vivo acetylcholine release in the hippocampus. Brain Res 1993, 618:341-345.
20. Inoue H., Li Y.P., Wagner J.A., Hersh L.B. Expression of the choline acetyltransferase gene depends on protein kinase A activity. J Neurochem 1995, 64:985-990.
21. Ishikawa K., Ott T., McGaugh J.L. Evidence for dopamine as a transmitter in dorsal hippocampus. Brain Res 1982, 232:222-226.
22. Izquierdo I., Dias R.D. Endogenous state-dependency:memory regulation by post-training and pre-testing administration of ACTH, beta -endorphin, adrenaline and tyramine. Braz J Med Biol Res 1983, 16:55-64.
23. Jamali-Raeufy N., Nasehi M., Ebrahimi-Ghiri M., Zarrindast M.R. Cross state-dependency of learning between WIN55, 212-2 and scopolamine in rat dorsal hippocampus. Neurosci Lett 2011, 491:227-231.
24. Jay T.M. Dopamine: a potential substrate for synaptic plasticity and memory mechanisms. Prog Neurobiol 2003, 69:375-390.
25. Jensen L.H., Stephens D.N., Sarter M., Petersen E.N. Bidirectional effects of beta-carbolines and benzodiazepines on cognitive processes. Brain Res Bull 1987, 19:359-364.
26. Kehr J., Yoshitake S., Ijiri S., Koch E., Noldner M., Yoshitake T. Ginkgo biloba leaf extract (EGb 761(R)) and its specific acylated flavonol constituents increase dopamine and acetylcholine levels in the rat medial prefrontal cortex: possible implications for the cognitive enhancing properties of EGb 761(R). Int Psychogeriatr 2012, 24(Suppl 1):S25-S34.
27. Klinkenberg I., Blokland A. The validity of scopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neurosci Biobehav Rev 2010, 34:1307-1350.
28. Levin E.D., Rose J.E. Interactive effects of D1 and D2 agonists with scopolamine on radial-arm maze performance. Pharmacol Biochem Behav 1991, 38:243-246.
29. Mahmoodi G., Ahmadi S., Pourmotabbed A., Oryan S., Zarrindast M.R. Inhibitory avoidance memory deficit induced by scopolamine: Interaction of cholinergic and glutamatergic systems in the ventral tegmental area. Neurobiol Learn Mem 2010, 94:83-90.
30. Memo M., Missale C., Trivelli L., Spano P.F. Acute scopolamine treatment decreases dopamine metabolism in rat hippocampus and frontal cortex. Eur J Pharmacol 1988, 149:367-370.
31. Nasehi M., Piri M., Nouri M., Farzin D., Nayer-Nouri T., Zarrindast M.R. Involvement of dopamine D1/D2 receptors on harmane-induced amnesia in the step-down passive avoidance test. Eur J Pharmacol 2010, 634:77-83.
32. Overton D.A. State-dependent learning produced by depressant and atropine-like drugs. Psychopharmacologia 1966, 10:6-31.
33. Packard M.G., White N.M. Dissociation of hippocampus and caudate nucleus memory systems by posttraining intracerebral injection of dopamine agonists. Behav Neurosci 1991, 105:295-306.
34. Pakpour B., Ahmadi S., Nayer-Nouri T., Oryan S., Zarrindast M.R. Inhibitory avoidance memory deficit induced by scopolamine: interaction with glutamatergic system in the nucleus accumbens. Behav Pharmacol 2010, 21:719-726.
35. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2006, Academic Press, Amsterdam.
36. Piri M., Zarrindast M.R. Nitric oxide in the ventral tegmental area is involved in retrieval of inhibitory avoidance memory by nicotine. Neuroscience 2011, 175:154-161.
37. Power A.E., Vazdarjanova A., McGaugh J.L. Muscarinic cholinergic influences in memory consolidation. Neurobiol Learn Mem 2003, 80:178-193.
38. Quartermain D., Leo P. Alleviation of scopolamine amnesia by different retrieval enhancing treatments. Pharmacol Biochem Behav 1988, 30:1093-1096.
39. Rezayof A., Motevasseli T., Rassouli Y., Zarrindast M.R. Dorsal hippocampal dopamine receptors are involved in mediating ethanol state-dependent memory. Life Sci 2007, 80:285-292.
40. Rezayof A., Alijanpour S., Zarrindast M.R., Rassouli Y. Ethanol state-dependent memory: involvement of dorsal hippocampal muscarinic and nicotinic receptors. Neurobiol Learn Mem 2008, 89:441-447.
41. Robinson L., Platt B., Riedel G. Involvement of the cholinergic system in conditioning and perceptual memory. Behav Brain Res 2011, 221:443-465.
42. Seamans J.K., Floresco S.B., Phillips A.G. D1 receptor modulation of hippocampal-prefrontal cortical circuits integrating spatial memory with executive functions in the rat. J Neurosci 1998, 18:1613-1621.
43. Shi J., Xue W., Zhao W.J., Li K.X. Pharmacokinetics and dopamine/acetylcholine releasing effects of ginsenoside Re in hippocampus and mPFC of freely moving rats. Acta Pharmacol Sin 2013, 34:214-220.
44. Snyder P.J., Bednar M.M., Cromer J.R., Maruff P. Reversal of scopolamine-induced deficits with a single dose of donepezil, an acetylcholinesterase inhibitor. Alzheimers Dement 2005, 1:126-135.
45. Wittmann B.C., Schott B.H., Guderian S., Frey J.U., Heinze H.J., Duzel E. Reward-related FMRI activation of dopaminergic midbrain is associated with enhanced hippocampus-dependent long-term memory formation. Neuron 2005, 45:459-467.
46. Zarrindast M.R., Dorrani M., Lachinani R., Rezayof A. Blockade of dorsal hippocampal dopamine receptors inhibits state-dependent learning induced by cannabinoid receptor agonist in mice. Neurosci Res 2010, 67:25-32.
47. Zarrindast M.R., Piri M., Nasehi M., Ebrahimi-Ghiri M. Nitric oxide in the nucleus accumbens is involved in retrieval of inhibitory avoidance memory by nicotine. Pharmacol Biochem Behav 2012, 101:166-173.
48. Zurkovsky L., Bychkov E., Tsakem E.L., Siedlecki C., Blakely R.D., Gurevich E.V. Cognitive effects of dopamine depletion in the context of diminished acetylcholine signaling capacity in mice. Dis Model Mech 2012, 6:171-183.